ART1 and lung carcinoma: Indeed, ART1 overexpression on lung cancer cells can enhance susceptibility to ART1-mediated ADP-ribosylation and to NICD in tumor-infiltrating P2 × 7R+CD8+ T cells, thereby constraining effective antitumor immunity and contributing to acquired resistance to immunotherapy [104].